Harrow Health, Inc.

Healthcare

NASDAQ:HROW · NASDAQ Global Market

Market Cap $1.56B Beta 0.28 P/E (TTM) -104.7

$42.87 +0.29%

+$0.12 today

52W Low $28.54High $54.85

Vol 1.03M · Avg 0.75M

EPS (TTM) -$0.40Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+38.29%

Period High

$54.80

Period Low

$29.03

Latest

$42.87

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Trevi Therapeutics, Inc.

NASDAQ:TRVI

$2.40B

Dynavax Technologies Corporation

DVAX

$1.82B

BioLife Solutions, Inc.

NASDAQ:BLFS

$1.26B

Alvotech

NASDAQ:ALVO

$1.22B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.12B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.07B

Evotec SE

NASDAQ:EVO

$928.82M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$845.48M

Phreesia, Inc.

NYSE:PHR

$584.12M

Tilray Brands, Inc.

NASDAQ:TLRY

$562.74M

What is the latest HROW filing?

The latest filing shown is 8-K dated Jun 3, 2026.

How many recent filings does HROW have?

Intrinsic Alpha currently shows 20 recent filings for HROW.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.